Regenerative Medical Technology (RMTG) Other Non-Current Assets (2020 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Other Non-Current Assets of $32538.0 for Q1 2026, up 347.94% year-over-year from $7264.0 in Q1 2025, and little changed quarter-over-quarter from $32538.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Regenerative Medical Technology's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $32538.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 347.94% year-over-year to $32538.0; the TTM figure through Mar 2026 stood at $32538.0 (up 347.94% YoY), while the FY2025 annual figure was $32538.0, up 347.94% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $32538.0, roughly flat from $32538.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $32538.0 in Q4 2025, with the low at $5568.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $7264.0 (2024), against an average of $10615.8.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets changed 0.0% in 2022, then surged 347.94% in 2025.
- Regenerative Medical Technology's Other Non-Current Assets stood at $5568.0 in 2022, then changed by 0.0% to $5568.0 in 2023, then jumped by 30.46% to $7264.0 in 2024, then soared by 347.94% to $32538.0 in 2025, then changed by 0.0% to $32538.0 in 2026.
- Business Quant data shows RMTG's Other Non-Current Assets at $32538.0 in Q1 2026, $32538.0 in Q4 2025, and $27264.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 32,538.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,538.00 |
| Dec 31, 2025 | 32,538.00 |
| Sep 30, 2025 | 27,264.00 |
| Jun 30, 2025 | 7,264.00 |
| Mar 31, 2025 | 7,264.00 |
| Dec 31, 2024 | 7,264.00 |
| Sep 30, 2024 | 7,264.00 |
| Jun 30, 2024 | 7,264.00 |
| Mar 31, 2024 | 7,264.00 |
| Dec 31, 2023 | 5,568.00 |
| Sep 30, 2023 | 5,568.00 |
| Jun 30, 2023 | 5,568.00 |
| Mar 31, 2023 | 5,568.00 |
| Dec 31, 2022 | 5,568.00 |
| Sep 30, 2022 | 5,568.00 |
| Jun 30, 2022 | 5,568.00 |
| Mar 31, 2022 | 5,568.00 |
| Dec 31, 2021 | 5,568.00 |
| Dec 31, 2020 | 175,000.00 |